Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2012
11/28/2012CN102397562B Method for preparing contrast agent obtained by supporting Gd<3+> by using Prussian blue
11/28/2012CN102274529B Magnetic resonance imaging contrast agent and preparation method thereof
11/28/2012CN102085382B Special sterilizing medical ultrasound couplant for ophthalmology and preparation method thereof
11/28/2012CN102083471B Novel mixed ligand core/shell iron oxide nanoparticles for inflammation imaging
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN101978971B Method for establishing enterovirus71 intramuscular injection-infected suckling mouse model
11/28/2012CN101642607B Low-strength focusing ultrasonic medicine release controlling and monitoring device based on array energy transducer
11/27/2012US8320994 Biopsy cavity marking device and method
11/27/2012US8320993 Subcutaneous cavity marking device
11/27/2012US8318209 Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
11/27/2012US8318136 Methods and systems for neural maintenance and regeneration
11/27/2012US8318134 Responsive paramagnetic MRI contrast agents
11/27/2012US8318133 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
11/27/2012US8317718 Methods of testing digestive functions using both a breath test and a scintigraphy test, and methods of using a breath test as an overall digestive health assessment
11/27/2012CA2738861C Photosensitizer composition for treating skin disorders
11/22/2012WO2012158527A2 Organophosphorous & multivalent metal compound compositions & methods
11/22/2012WO2012157821A1 Variable color two-photon fluorescent probe, method for imaging thiol activation in mitochondrion using same, and method for manufacturing the variable color two-photon fluorescent probe
11/22/2012WO2012156372A1 Intraocular tissue staining system
11/22/2012US20120296207 Post-biopsy cavity treatment implants and methods
11/22/2012US20120295950 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
11/22/2012US20120294809 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
11/22/2012US20120294808 Fluorescent Analogs of Neurotransmitters, Compositions Containing the Same and Methods of Using the Same
11/22/2012US20120294807 Fluorescent compounds
11/22/2012US20120294806 Drug carrier with thermal sensitivity, manufacturing method thereof, and use thereof
11/22/2012US20120294805 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
11/22/2012US20120294804 Phenylethanolamine-based nmda receptor antagonists
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012US20120294801 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012DE102011101952A1 Mit dendritischem Polyglycerolsulfat funktionalisierte Nanopartikel With dendritic polyglycerol sulfate functionalized nanoparticles
11/21/2012EP2524702A1 Diagnostic for cancer
11/21/2012CN102788874A Method for evaluating cigarette harm degree by using primate animal models
11/21/2012CN102784400A Brain tumor magnetic resonance contrast agent and its preparation method
11/20/2012US8313779 Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same
11/20/2012US8313745 Compositions against cancer antigen LIV-1 and uses thereof
11/20/2012US8313731 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
11/20/2012US8313730 Treatment of celiac disease with IgA
11/20/2012US8313729 Integrated photoactive small molecules and uses thereof
11/15/2012WO2012155085A1 Fe(ii) sequestering agents and uses thereof
11/15/2012WO2012155076A2 Imaging contrast agents and uses thereof
11/15/2012WO2012155055A2 Integrin-targeted imaging of inflammation in vascular remodeling
11/15/2012WO2012154885A2 Carbonic anhydrase targeting agents and methods of using same
11/15/2012WO2012154661A1 Echogenically enhanced device
11/15/2012WO2012154656A1 Device with echogenic coating
11/15/2012WO2012154654A2 Methods for imaging bone precursor cells using dual-labeled imaging agents to detect mmp-9 positive cells
11/15/2012WO2012153820A1 X-ray absorbing fluorescent nanoparticle
11/15/2012WO2012153493A1 Photodynamic therapy or diagnostic agent, using infrared-spectrum light
11/15/2012WO2012153273A1 A process for delivering encapsulated neutral bioimaging molecules, complex, and process thereof
11/15/2012WO2012152807A1 Activity-based probes for the urokinase plasminogen activator
11/15/2012WO2012151768A2 Method and use for constructing monkey model compounding deficiency syndrome of traditional chinese medicine and aids
11/15/2012WO2012125693A3 Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
11/15/2012US20120291146 Assays of Neurodegenerative Disorders, including Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
11/15/2012US20120291145 Transgenic mice over-expressing receptor for advanced glycation endproduct (rage) in brain and uses thereof
11/15/2012US20120289679 Novel mite allergen
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288447 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/15/2012US20120288446 Organophosphorous & multivalent metal compound compositions & methods
11/15/2012US20120288442 Nuclear Imaging Method Using Molecular Target Detection Agent for Liver Fibrosis
11/15/2012CA2836401A1 Echogenically enhanced device
11/15/2012CA2836379A1 Device with echogenic coating
11/15/2012CA2835298A1 Pretargeting kit for imaging or therapy comprising a trans - cyclooctene dienophile and a diene
11/15/2012CA2835286A1 Carbonic anhydrase targeting agents and methods of using same
11/15/2012CA2835217A1 Activity-based probes for the urokinase plasminogen activator
11/15/2012CA2835214A1 Integrin receptor antagonists and their methods of use
11/14/2012EP2522368A1 Microparticles for intraocular tissue marking
11/14/2012EP2522366A1 Targeting agent for tumor site
11/14/2012EP2522349A1 Water-Soluble Anionic Bacteriochlorophyll Derivatives and their Uses
11/14/2012EP2521791A1 Method for selecting bacteria with anti-oxidant action
11/14/2012CN1960707B Liposomal assembly for therapeutic and/or diagnostic use
11/14/2012CN102781974A Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof
11/14/2012CN102781909A N-alkoxyamide conjugates as imaging agents
11/14/2012CN102781478A Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
11/14/2012CN102778562A Cytotoxicity mediation of cells evidencing surface expression of CD44
11/14/2012CN102776220A Construction of brucellosis A19 molecular marker vaccine strain and determination of virulence and immunogenicity
11/14/2012CN102775472A Aprotinin and analogue as carriers across the blood-brain barrier
11/14/2012CN102775078A Degradable phenylboronic acid/mucin layer-by-layer self-assembled ultrathin film responsive to concentration of saccharides
11/14/2012CN102772808A Multi-modality imaging microbubble structure, preparation method and applications
11/14/2012CN102772807A High-water-solubility nuclear magnetic resonance imaging contrast agent and preparation method thereof
11/14/2012CN102441178B Chinese medicinal development assistant for B-type ultrasonography
11/14/2012CN102380108B Quick-hardening contrast agent special for defecography
11/14/2012CN102218146B ShRNA (Short Hairpin Ribonucleic Acid) kit for treating animal model suffered from alzheimer disease
11/14/2012CN101652149B Imaging probes
11/13/2012US8309060 Abuse-proofed dosage form
11/13/2012US8309057 Methods for elevating neurotrophic agents
11/13/2012US8309056 Method for determination of oxidative stress
11/08/2012WO2012151577A2 Techniques to increase r1 in nanoparticle contrast agents for mri
11/08/2012WO2012151539A2 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
11/08/2012WO2012151464A2 Use of radiographic contrast agents for detecting dental caries
11/08/2012WO2012150302A1 Tetraaza-cycloalkanes based ligands and their use in nuclear medicine and molecular imaging
11/08/2012WO2012150220A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012WO2012149644A1 Novel agonists and antagonists of the urotensinergic system
11/08/2012WO2012149622A1 Skin test for diagnosing subclinical caseous lymphadenitis in goats and sheep
11/08/2012WO2012078647A3 Chemical composition to detect and treat amyloid in a patient's brain and retina
11/08/2012WO2011135369A8 Diagnostic reagents
11/08/2012US20120283503 Nanoparticle loaded stem cells and their use in mri guided hyperthermia
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282186 Templated nanoconjugates
11/08/2012US20120282185 Particles for the treatment of cancer in combination with radiotherapy
11/08/2012US20120282184 Treatment of obesity
11/08/2012US20120282183 Prognostic,. screening and treatment methods and agents for treatment of metastasis and inflammation using 5t4 oncofoetal glycoprotein
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 354